The Food and Drug Administration issued an “early alert” concerning FreeStyle Libre 3 and FreeStyle Libre Plus sensors used by people who have diabetes. The agency said Abbott Diabetes Care has sent a ...
(RTTNews) - Abbott Laboratories (ABT) has initiated a medical device correction in the United States for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus continuous glucose monitoring systems ...
Incorrect low glucose readings from some Abbott continuous glucose monitoring (CGM) sensors have been potentially linked to 736 severe adverse events and seven deaths globally. Abbott reported this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results